Moon Surgical has announced the appointment of Anne Renevot as the company’s Chief Financial Officer (CFO). Anne brings over three decades of experience in public and private finance.
“We are delighted to welcome Anne as a key member of our executive leadership team,” said Anne Osdoit, CEO of Moon Surgical and a Partner in Sofinnova Partners’ medtech accelerator, MD Start. “Her financial expertise, gained from her tenure as CFO at fast-growing and innovative MedTech capital equipment companies such as EOS imaging will be crucial for shaping our financial operations to navigate an ever-changing economic environment.”
“I am honored to join a company that has developed and manufactures the Maestro System in-house in Europe and the US, especially at this pivotal time as Moon Surgical prepares for a commercial launch,” said Anne Renevot, CFO of Moon Surgical. “Being part of a company that offers a product with tangible impact on how surgeons treat patients is very exciting.”
Prior to joining Moon Surgical, Anne Renevot was the CFO of Poxel, a publicly-traded French biotech company. Before that, she was CFO of EOS imaging, where she played a vital role in completing the company’s €40 million IPO on NYSE Euronext Paris. Anne also held senior finance positions in manufacturing and international controlling at Cartier. She started her career at EY.
Source: Moon Surgical